With growth rolling over and liquidity gradually coming back, the stage is set for a return to perhaps smaller-cap equity leadership. Small caps have been stymied by high borrowing costs, as small ...

Mid-cap companies under Motilal Oswal’s coverage have now clocked their fourth consecutive quarter of standout performance, ...

This is part of a series of interviews with the winners of The Economic Times Startup Awards 2025. As India’s pipeline of new-age initial public offerings (IPOs) swells, the ecosystem must look beyond ...

Nuveen is the latest strategist to bet that smaller caps will outrun large peers amid shrinking recession fears.

Small-cap stocks have lagged behind their larger counterparts for more than 20 years, leaving beleaguered small-cap investors ...

Small-cap stocks rarely receive the spotlight, yet today’s U.S. backdrop appears to be shifting decisively in their favor.

If your keyboard keeps typing in caps even when the caps lock is off in Windows 11/10, check your keyboard and use these ...

Small-cap stocks were looking at back-to-back losses Tuesday amid a selloff that's also sweeping up Big Tech. The Russell 2000 index of small-cap stocks was down about 1%, at last check, whereas an ...

Unprofitable companies in the Russelll 2000 have outpaced profitable constituents in the index. Some investors think small-caps can keep rising, citing more affordable valuations and expectations of ...

The Fed decision hits at 2PM ET, with markets pricing a 99.9% chance of a rate cut today and a 91% chance of another in December. While the move is already priced in, the commentary will set the tone.

The Global Generic Drugs Market, valued at USD 487.21 Billion in 2024, is poised to reach USD 898 Billion by 2035, advancing at a CAGR of 5.75% from 2025 to 2035. As healthcare systems worldwide push ...

MA's rising earnings outlook and global momentum fuel optimism, but premium valuation and mounting regulatory risks temper ...